MMA
EW icon

Miracle Mile Advisors’s Edwards Lifesciences EW Stock Holding History

Miracle Mile Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Buy
9,568
+247
+3% +$20.7K 0.01% 476
2026
Q1 		$746K Sell
9,321
-10
-0.1% -$824 0.01% 485
2025
Q4 		$795K Buy
9,331
+147
+2% +$12.1K 0.01% 465
2025
Q3 		$714K Sell
9,184
-1,488
-14% -$116K 0.01% 480
2025
Q2 		$835K Sell
10,672
-577
-5% -$43K 0.01% 398
2025
Q1 		$815K Buy
11,249
+78
+0.7% +$5.58K 0.02% 358
2024
Q4 		$827K Buy
11,171
+509
+5% +$35.6K 0.02% 360
2024
Q3 		$704K Buy
10,662
+38
+0.4% +$2.76K 0.02% 320
2024
Q2 		$981K Sell
10,624
-254
-2% -$22.5K 0.02% 266
2024
Q1 		$1.04M Buy
10,878
+1,507
+16% +$127K 0.03% 267
2023
Q4 		$715K Buy
9,371
+1,074
+13% +$74.7K 0.02% 297
2023
Q3 		$575K Hold
8,297
– – 0.02% 308
2023
Q2 		$783K Sell
8,297
-899
-10% -$78.1K 0.02% 291
2023
Q1 		$761K Buy
9,196
+899
+11% +$70.7K 0.02% 313
2022
Q4 		$619K Hold
8,297
– – 0.02% 326
2022
Q3 		$686K Buy
8,297
+27
+0.3% +$2.6K 0.03% 247
2022
Q2 		$786K Sell
8,270
-4
-0% -$414 0.04% 247
2022
Q1 		$974K Sell
8,274
-772
-9% -$86.6K 0.04% 239
2021
Q4 		$1.17M Buy
9,046
+14
+0.2% +$1.63K 0.05% 226
2021
Q3 		$1.02M Sell
9,032
-21
-0.2% -$2.4K 0.05% 221
2021
Q2 		$938K Buy
9,053
+767
+9% +$72.3K 0.05% 206
2021
Q1 		$693K Sell
8,286
-1,565
-16% -$132K 0.04% 227
2020
Q4 		$899K Buy
9,851
+2,603
+36% +$216K 0.06% 215
2020
Q3 		$579K Buy
+7,248
New +$566K 0.04% 231
2020
Q1 		– Sell
-2,934
Closed -$228K – 286
2019
Q4 		$228K Buy
2,934
+87
+3% +$6.79K 0.02% 273
2019
Q3 		$209K Buy
+2,847
New +$200K 0.01% 265

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Miracle Mile Advisors's EW Position: Q2 2026 in Review

Miracle Mile Advisors increased its Edwards Lifesciences (EW) stake by 2.6% in Q2 2026, buying an estimated $20.7K and bringing the position to 9,568 shares worth $866K. The position accounts for 0.01% of the portfolio, ranked #476.

Miracle Mile Advisors first reported a position in EW in Q3 2019 and has held it in 26 quarters since. The position peaked at $1.17M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Miracle Mile Advisors held 9,568 shares of Edwards Lifesciences worth $866K as of Q2 2026.
  • Miracle Mile Advisors bought 247 Edwards Lifesciences shares in Q2 2026, an estimated $20.7K.
  • Edwards Lifesciences made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #476 holding.
  • Miracle Mile Advisors first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 26 quarters since.
  • Miracle Mile Advisors's Edwards Lifesciences position peaked at $1.17M in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.